MARKSANS PHARMA
Back to Cashflow Statement
|
MARKSANS PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹93 Cr | ₹21 Cr | ₹176 Cr | ₹94 Cr | ₹118 Cr |
What is the latest Net Cash Inflow / Outflow ratio of MARKSANS PHARMA ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2025 | ₹93 Cr |
Mar2024 | ₹21 Cr |
Mar2023 | ₹176 Cr |
Mar2022 | ₹94 Cr |
Mar2021 | ₹118 Cr |
How is Net Cash Inflow / Outflow of MARKSANS PHARMA Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2025 | ₹93 Cr | 343.90 | |
Mar2024 | ₹21 Cr | -88.16 | |
Mar2023 | ₹176 Cr | 86.52 | |
Mar2022 | ₹94 Cr | -20.33 | |
Mar2021 | ₹118 Cr | - |
Compare Net Cash Inflow / Outflow of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹10,178.9 Cr | -0.8% | -13.4% | 7.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,864.0 Cr | -4.3% | -3% | -0.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹168,811.0 Cr | -3.3% | -7.4% | 34.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,352.0 Cr | 1.4% | 10.1% | 17.9% | Stock Analytics | |
CIPLA | ₹121,260.0 Cr | -4.4% | -0.5% | 0.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,786.0 Cr | -5.2% | -5.7% | -5.9% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | -0.8% |
-13.4% |
7.9% |
SENSEX | -1.1% |
-3.4% |
-1.1% |
You may also like the below Video Courses